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We introduce a non-invasive approach for optogenetic regulation in biological cells through highly 
scattering skull tissue using wavefront shaping. The wavefront of the incident light was systematically 
controlled using a spatial light modulator in order to overcome multiple light-scattering in a mouse skull 
layer and to focus light on the target cells. We demonstrate that illumination with shaped waves enables 
spatiotemporal regulation of intracellular Ca2+ level at the individual-cell level.  
Recently research has indicated significant potentials of optogenetics, light-controlled regulation of cell 
functions exploiting genetically modified light-sensitive proteins1,2. These have been demonstrated in various 
applications ranging from neuroscience3 and cardiology4, to genetics5. Recently, a significant breakthrough in 
optogenetics has been achieved by in vivo functional studies3,4. However, attempts toward in vivo optogenetics 
have been stymied by a fundamental limitation—light scattering. Multiple light scattering significantly limits 
light delivery through turbid media such as brain or skull layers (Fig. 1a). Consequently, existing in vivo 
optogenetic approaches rely on invasive methods including cranial windows involving skull removal or 
thinning6, and invasive implementation of an optical fiber7 (Fig. 1b). Although these methods extend the 
accessibility of optogenetics to deep tissue regions, unwanted cellular activities and tissue damage are 
inevitable. Recently developed red-shifted light-sensitive proteins, which absorb near-infrared (NIR) light8, 
showed deep light penetration through biological tissues, but penetration depth of NIR light is still limited to a 
few millimeters due to multiple light scattering.  
To deliver a controlled light through highly scattering tissues towards non-invasive in vivo optogenetic 
control, we exploit wavefront shaping techniques (Fig. 1c). Without controlling the incident wavefront, light 
diffuses out as it propagates through optically inhomogeneous complex media such as tissues, resulting in the 
formation of speckle patterns. This speckle pattern seems stochastic due to the complex distribution of intensity 
patterns. However, the speckle formation results from light interference, which is a deterministic process and 
thus can be systematically controlled by changing the incident wavefront9. We show that the shaped wavefront 
of an incident excitation light generates optimized focus through 300 µm-thick mouse skull. This enables the 
spatiotemporal regulation of intracellular Ca2+ level of the irradiated cell, by activating the light-sensitive 
proteins.  
 
Results 
Focusing through a highly scattering skull layer using wavefront shaping 
In order to demonstrate that the wavefront shaping of excitation beams enables the generation of selective 
focus through a highly scattering skull layer and thereby the optogenetic regulation of signaling-pathways in 
individual cells, we used an in vitro model system in which a spatial light modulator (SLM) was employed for 
wavefront shaping (Fig. 2a). The experimental setup consists of two parts: the wavefront shaping part for 
activating light-sensitive proteins and the fluorescence imaging part for measuring cellular responses (Fig. 2b). 
To demonstrate the capability of optogenetic control through scattering tissues, a skull layer dissected from a 
mouse without a thinning procedure was prepared. The dissected skull layer was then attached to the bottom of a 
culture plate in which cells were dispersed in a monolayer. Thickness of the dissected skull was approximately 
300 µm, measured from the second harmonic generation image (Fig. 2c). This was thick enough to scramble the 
incident laser beam into speckle patterns.  
To systematically and precisely generate focus though a turbid medium, we used an algorithm modified 
from parallel optimization10. The parallel algorithm optimizes half a field of SLM pixels using the other half as a 
reference. After optimizing one-half of the SLM pixels, light intensity at the focus is increased to the half-
maximum intensity of the optimized focus. However, increased intensity at the target region after optimizing 
half of the SLM pixels could excite light-activating proteins and activate unwanted cellular responses. This 
would disturb the experimental results. Alternatively, we optimized both halves of the SLM pixels separately, 
and then the optimal SLM pattern was calculated by adding the relative phase value to one half of the optimized 
SLM pixels, while the values of the other half of the SLM pixels remained constant (Supplementary Fig. 1). 
This modified parallel algorithm prevents activation of cellular responses during the optimization process. With 
the optimized SLM pixels, optical focus of the excitation laser was formed clearly after passing through the 
brain skull layer, whereas an uncontrolled wavefront only generate diffused light or a speckle pattern (Fig. 2d). 
The FWHM size of the generated focus was 1.905 ± 0.224 µm, which is small enough to regulate optogenetic 
components as the subcellular resolution. 
In principle, the intensity enhancement of an optimized focus η is proportional to the number of SLM pixels 
used N as,η = (π/4)⋅(N - 1) + 1.11 The use of large number of SLM pixels, and thus the increased optimization 
time, makes the optimization process vulnerable to the addition of more noise, which is obviously undesirable 
for in vivo applications. In order to reduce optimization time while maintaining the desirable degree of control 
for wavefront shaping, we grouped SLM pixels into N equally sized square segments. For the experiments, we 
used N = 55 and 110, and the corresponding optimization times were 84.79 s and 140.05 s, respectively. The 
measured η for experiments with the brain tissue only, were 52 (N = 110) and 28.4 (N = 55) (Fig. 2e). However, 
η was decreased with live cells located on the top of the brain tissue: η = 30.6 (N = 110) and 14.5 (N = 55). 
Under live-cell conditions, cellular and intercellular movements, and fluctuation of the culture medium, may 
adversely affect the optimization process. Nonetheless, η = 14.5 is high enough for the spatiotemporal control 
of light-activating proteins in vitro.  
To investigate the relation between skull thickness and the enhancement in intensity of optimized foci, we 
stacked mouse skull layers and then measured the intensity of optimized foci (Fig. 2f). We found that η was 
relatively constant regardless of skull thickness: η = 46.0 (1 skull layer), η = 46.5 (2 skull layers), and η = 42.5 
(3 skull layers). However, the measured total transmittance T and intensity of optimized foci were decreased as 
skull thickness increases. Measured T were 54.9%, 20.2%, and 10.5%, and intensity of optimized foci were 
3342  ± 748, 359 ± 37, and 170 ± 23 (arbitrary unit), for 1, 2 and 3 skull layers, respectively. (Fig. 2f). 
Theoretially, T in the diffusive regime (L >> ls) is can be written as follows12,13, 
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where L is the thickness of a turbid medium, ls is mean free path, and R is total reflectance. This relation 
indicates that T is inversely proportional to thickness of a turbid medium. In our experiments, the measured T 
and intensity of optimized foci through mouse skull were inversely proportional to skull thickness, which is 
consistent with theoretical expectation from Eq. (1) (Fig. 2f). Next, we measured the transport mean free path 
(TMFP) of frontal and parietal region of a mouse skull according to mouse strains and ages. The TMFP is 
defined as the average distance in which light completely losses its original propagation direction, which 
provides intuitive understanding of the degree of turbidity of complex media14. TMFPs of frontal and parietal 
bones were measured as 0.34 ± 0.13 and 0.15 ± 0.03, respectively (Fig. 2g). Measured TMFPs show significant 
difference between frontal and parietal bones, but no difference according to mouse strains and ages 
(Supplementary Table 1). Measured TMFPs are also consistent with previous reports 14,15.  
Spatiotemporal regulation of intracellular Ca2+ activity with a shaped wave irradiation 
To test whether an optimized focus through the skull enables spatial control of light-sensitive proteins, we 
performed in vitro experiments using HeLa cells expressing optoFGFR1. OptoFGFR1 is a photoactivatable 
receptor tyrosine kinase which is activated by blue light (488 nm), and induces Ca2+ release from the 
endoplasmic reticulum through downstream signaling pathway16. To measure the intracellular Ca2+ level, R-
GECO1, which emits red fluorescence by binding of Ca2+ ions, was co-expressed with optoFGFR1 in HeLa 
cells. First, the mouse skull was irradiated using an uncontrolled plane wave (6 µW) through a high-NA 
objective lens, for 60–200 s. The beam transmitted through the mouse skull exhibited a speckle pattern, and all 
the cells inside the field of view were irradiated by the speckle light field (Fig. 3a). After illumination with the 
plane wave, not only the target cell but also adjacent cells showed overall increases in R-GECO1 signals (Fig. 
3b). Then, we optimized the wavefront of the incident beam in order to focus the beam in the middle of the 
target cell, 15 min after the plane wave illumination (Fig. 3a). Illumination with the optimized shaped wave, 
with less power (2 µW), specifically induced R-GECO1 signal increases only in the target cell; adjacent cells 
did not exhibit significant changes in R-GECO1 signals (Fig. 3c). These results demonstrate that the wavefront 
shaping method enables spatial control of light-sensitive proteins at the subcellular resolution to specifically 
activate individual single cells through the highly scattering skull layer. 
Temporal regulation and reversibility of optoFGFR1 activity were also accessed by repeated irradiations 
with the shaped wave onto HeLa cells behind the skull tissue. First irradiation of the target cell with the shaped 
wave (2 µW) increased R-GECO1 fluorescence signals only in the target cell (Fig. 3d). After withdrawal of 
light irradiation, we waited for an additional 18 min to recover the activity of optoFGFR1 in the irradiated cells. 
Then, we optimized a wavefront of the incident light again, and the R-GECO1 fluorescence signal in the same 
target cell was elevated again upon the second irradiation with the shaped wave (Fig. 3e). The levels of cellular 
response were similar in both irradiations with the shaped wave.  
 
Discussion 
In summary, this study provided the first in vitro demonstration of optogenetic control through a highly 
scattering skull layer using the wavefront shaping technique. By controlling the wavefront of an excitation beam 
impinging through the skull layer using a SLM, we experimentally demonstrated that optoFGFR1 expressing 
cells lying beyond the skull could be regulated spatiotemporally. This resulted in optical control of increased 
intracellular Ca2+ levels in the activated cells. 
   In its present embodiment, the wavefront shaping was performed using transmission geometry. In the future, 
for in vivo applications involving live animals, the present method should be implemented using reflection 
geometry. This may require additional techniques such as optical phase conjugation17,18, photo-acoustically 
tagged light19, and wavefront-shaping optical coherence tomography20. Another limitation in the current study is 
the long optimization time due to the slow refresh rate of SLMs. Alternatively, dynamic mirror devices or 
deformable mirrors could be used to expedite the optimization process. Nonetheless, the present work provided 
the first demonstration of the importance of wavefront shaping techniques towards non-invasive in vivo 
optogenetic studies. Furthermore, the wavefront shaping approach provide large degrees of freedom in 
controlling the light, allowing the control of polarization21, wavelength22, spatiotemporal focusing23, coherence 
gating for depth selection20,24, and sub-wavelength information25,26. In addition, approaches based on scattering 
matrices14,26-30 can also be applied to realize full-field optogentic control. Our approach allows an improvement 
in the applicability of optogenetics and should find widespread applications in ex vivo tissue models and for 
non-invasive regulation of light-sensitive proteins in vivo. 
 
Methods 
Cell preparations 
HeLa cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) (catalog no. 11995-065, Gibco) 
supplemented with 10% fetal bovine serum (catalog no. 26140-079, Gibco) at 37°C with 10% CO2. HeLa cells 
were transfected with optoFGFR1 and R-GECO1 by using Neon transfection system (catalog no. MPK5000, 
Invitrogen) according to manufacturer’s instruction. For live cell imaging, transfected cells were plated on 40 
mm dish (catalog no. 93040, TPP) and serum-starved with serum-free DMEM for 6hr. After starvation, all 
experiments were performed in a dark condition for protection HeLa cells from light. OptoFGFR1 construct was 
used as previously reported16. R-GECO1 plasmid was a gift from Robert Campbell (Addgene plasmid # 
32444).31 
Mouse skull preparation 
For mimicking intact brain, we used a whole dissected mouse skull. All experiments used 7- to 10-week-old 
male Balb/c mice (Orient Bio Inc., Republic of Korea). The sample preparation procedures and the methods 
were approved by the Institutional Review Board (IRB project number: KA2013-15) and all the experiements 
were performed in accordance with the approved guidelines and regulations. The head was removed after 
euthanizing mouse. The scalp and muscles were eliminated using stainless-steel scissors. Then, the skull was 
gently dissected with a rongeur heading from the neck toward the nose. The dissected mouse skull was 
immersed in phosphate-buffered saline (Welgene Inc., Republic of Korea) for 24 hours to remove blood. Before 
experiments, the dissected mouse skull was dried and then attached at the bottom of the culture dish using a 
transparent double-sided tape. The transmittance and reflectance of the sample were measured using an 
integrating sphere. Then the reduced scattering coefficient was calculated from the inverse-adding doubling 
method.32 The reduced scattering parameter of the skull was measured as 3.297 mm-1. 
Optical setup 
Optical setup is composed of two parts; the wavefront shaping part for the excitation beam and the fluorescence 
imaging part for measuring R-GECO1 signals. A continuous-wave laser diode (λ = 488 nm, 60 mW, Cobolt) is 
used to activate optoFGFR1 which absorbs a wavelength of 488 nm. A beam from the laser diode is expended 
by 4f lens system to cover whole active area of the SLM before passing through a half-wave plate (WPH10E-
488, Thorlabs) and a polarizer (LPVISE100-A, Thorlabs). The SLM (X10468-01, Hamamatsu Photonics Inc. 
Japan) is placed at a conjugate image plane of the mouse skull. A CCD camera (Lt365R, Lumenera Inc., USA) 
is used as a detector for both the wavefront shaping and the fluorescence signals. For measuring fluorescence 
images, a LED (λ = 565 nm, 880 mW, Thorlabs) is used to excite the R-GECO1 of which excitation and 
emission peaks are 561 nm and 600 nm, respectively. Bandpass filters are used as excitation (FF01-561/14-25, 
Semrock, Rochester, NY, USA) and emission (FF01-607/36-25, Semrock, Rochester, NY, USA) filters 
Wavefront shaping process 
In order to optimize a wavefront of the incident light, we used an algorithm modified from the parallel 
wavefront optimization method10 to utilize the entire active area of the SLM for wavefront shaping. In our 
system, the SLM is directly projected onto the mouse skull; in other words, each SLM segments has a one-to-
one correspondence to a positon on the mouse skull. The SLM pixels were grouped into N (N = 55, 110) equally 
sized square segments to avoid oversampling situation, and to reduce calculation time. Wavefront shaping 
procedure consists of three steps (Supplementary Fig. 1a). First, the one half (left panel) of the SLM segments is 
modulated, while the other half (right panel) of the SLM segments is fixed with a constant phase value. After 
finishing optimization of the left panel of the SLM segments, optimized phase values are recorded. Then, the 
phase values of the left panel of the SLM segments was reset to a constant phase (usually zero), while 
modulating the right panel of the SLM segments. After optimization of both panels of the SLM segments, the 
phase matching process was performed in order to find the value of a relative phase difference between two 
panels (Supplementary Fig. 1b). The optimized phase values are applied to both left and right panels. Then by 
monitoring the intensity of the generated focus, the left half of the SLM segments is fixed and the right panel of 
the SLM segments is added with a constant phase value between 0 and 2π. The phase value which gives the 
maximum intensity is selected for finding the optimized SLM segments.  
Image analysis 
All image analysis were performed using Matlab and ImageJ softwares. 
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Figure legends 
 
 
Figure 1 | Schematics of current optical delivery methods for in vivo optogenetics and the proposed concept: (a) 
Focusing with a conventional lens results in light diffusion due to multiple light scattering in a skull and brain 
tissues. (b) Irradiation of target regions using an implanted optical fiber is invasive and causes tissue damage 
(green color). (c) Illumination with a shaped beam can enable light focusing inside tissues without invasive 
processes such as skull thinning or optical fiber implantation.  
 
 
Figure 2 | Optical focusing through a skull layer using wavefront shaping technique: (a) Schematic of the 
experiment. Cells expressing both optoFGFR1 and R-GECO1 are placed above the skull layer. When 
illuminating with a plane wave through an objective lens, the beam undergoes multiple light scattering as it 
propagates through the skull and this diffused light may activate optigenetic signals in all cells in an 
uncontrolled manner (left). By shaping the wavefront of the impinging beam using SLM, optical focus can be 
generated at the plane of the cells, thus activating optogenetic regulation at the level of individual cells (right). 
(b) Experimental setup, L1-3 lens: The blue dashed box indicates a wavefront shaping part, and the red dashed 
box indicates a fluorescence-imaging part. (c) Confocal image of second harmonic generation signals in the 
used mouse skull on the x-y plane (left) and in the axial direction (right). Scale bar 500 µm. (d) Intensity images 
of the transmitted beam through the skull without wavefront shaping (left), and with the wavefront shaping 
(right). (e) Measured intensity enhancements according to segment numbers and samples. (f) Measured intensity 
of optimized foci (n = 5) and intensity enhancements (n = 5) according to numbers of skull layers. The graph 
inset illustrates the optical transmittance according to numbers of skull layers. The circles represent 
experimental data, and a dashed line is a theoretically expected from Eq. (1). (g) Measured transport mean free 
path of the frontal (n = 4) and parietal bones (n = 4), respectively. Schematic of a mouse skull (top) and 
corresponding transport mean free paths of the mouse skull (bottom).  
 
 
Figure 3 | Spatiotemporal regulation of intracellular Ca2+ level in HeLa cells co-expressing optoFGFR1 and R-
GECO1, using wavefront shaping: (a) Targeted activation of Ca2+ signaling in HeLa cells after focusing through 
the skull. Gray color indicates R-GECO1 fluorescence signals. Green indicates excitation beam intensity 
through the skull without wavefront shaping, and cyan indicates optimized focus with wavefront shaping. The 
white arrow indicates the location of the optimized focus. The dashed lines indicate boundaries of individual 
cells. The red dashed line indicates the target cell. Quantitative analysis of R-GECO1 fluorescence signals 
obtained from cells i–iv in (a), with a plane wave (b), and with the shaped wave (c). The blue bar and the blue 
checked bar indicate irradiation time of a plane wave and the shaped wave, respectively. (d) Reversible control 
of Ca2+ level induced by optoFGFR1 in HeLa cells with repeated illumination using a shaped wave. 
Representative images show the baseline (left, no illumination) and maximal (right, shaped-wave illumination) 
R-GECO1 fluorescence signals. The dashed lines indicate each cell boundary. Red indicates the target cell. (e) 
Quantitative analysis of R-GECO1 fluorescence signals obtained from cells in (d). The cells were repeatedly 
illuminated using shaped waves. Each color matches the cells in (d). The blue-checked bars indicate irradiation 
time of the shaped wave.  
